These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20627056)

  • 1. [Relationship of methylation of promoter and expression of PTEN gene in papillary thyroid carcinoma].
    Yin DT; Yin FY; Zheng LY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 45(4):330-3. PubMed ID: 20627056
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of genes in papillary thyroid carcinoma.
    Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcription and promoter hypermethylation of thyroid stimulating hormone receptor gene in human papillary thyroid carcinoma].
    Dai YL; Cai DH; Chen H; Zhang Y; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):114-7. PubMed ID: 20117998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
    Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN promoter methylation in sporadic thyroid carcinomas.
    Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
    Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
    Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X
    Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand (FasL, Apo-1L/CD95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
    Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between thyroid-stimulating hormone-peroxiredoxin1 signaling pathway and invasion of papillary thyroid carcinoma].
    Liu X; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 44(4):287-91. PubMed ID: 19558833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression.
    Scarpino S; Di Napoli A; Rapazzotti-Onelli M; Pilozzi E; Ruco L
    Br J Cancer; 2004 Aug; 91(4):703-6. PubMed ID: 15266330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma.
    Cheng SP; Chi CW; Tzen CY; Yang TL; Lee JJ; Liu TP; Liu CL
    Surgery; 2010 Jun; 147(6):847-53. PubMed ID: 20045163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas.
    Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N
    Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
    Beg S; Siraj AK; Jehan Z; Prabakaran S; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
    Br J Cancer; 2015 Jun; 112(12):1938-43. PubMed ID: 25989274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial thyroid carcinoma: a diagnostic algorithm.
    Dotto J; Nosé V
    Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary and non-medullary thyroid cancer in a family.
    Ardern-Jones A; Harvey RJ; Wilson P; Sharma AK; Murday V; Harmer C; Houlston RS
    Acta Oncol; 2004; 43(7):680-1. PubMed ID: 15545189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.